151751-Najiba-Chargi

135 Surgery: skeletal muscle mass, systemic inflammation and flap reconstruction REFERENCES 1. Ishimaru M, Ono S, Suzuki S, Matsui H, Fus - himi K, Yasunaga H. Risk factors for free flap failure in 2,846 patients with head and neck cancer: A National Database Study in Japan. J Oral Maxillofac Surg . 2016;74(6):1265-1270. doi:10.1016/j.joms.2016.01.009 2. Kwok AC, Agarwal JP. An analysis of free flap failure using the ACS NSQIP database. Does flap site and flap typematter? Microsurgery . 2017;37(6):531-538. doi:10.1002/micr.30121 3. Mücke T, Ritschl LM, RothM, et al. Predictors of free flap loss in the head and neck region: A four-year retrospective study with 451mi- crovascular transplants at a single centre. J Cranio-Maxillofacial Surg . 2016;44(9):1292- 1298. doi:10.1016/j.jcms.2016.04.029 4. Zhao B, Zhang J, Zhang J, et al. The Impact of Preoperative Underweight Status on Postoperative Complication and Survival Outcome of Gastric Cancer Patients: A Sys - tematic Review and Meta-analysis. Nutr Cancer . 2018;70(8):1254-1263. doi:10.1080 /01635581.2018.1559937 5. Baracos VE, Arribas L. Sarcopenic obesity: Hidden muscle wasting and its impact for survival and complications of cancer ther- apy. Ann Oncol . 2018;29(suppl_2):ii1-ii9. doi:10.1093/annonc/mdx810 6. Hua X, Liu S, Liao JF, et al. When the Loss Costs Too Much: A Systematic Review and Meta-Analysis of Sarcopenia in Head and Neck Cancer. Front Oncol . 2020;9:1561. doi:10.3389/fonc.2019.01561 7. Baracos VE, Arribas L, Baracos VE. Sarco - penic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy. Cancer and Cachexia . 2018;29:ii1-ii9. doi:10.1093/annonc/mdx810 8. Nobuoka D, Gotohda N, Kato Y, Takahashi S, Konishi M, Kinoshita T. Influence of excess body weight on the surgical out- comes of total gastrectomy. Surg Today . 2011;41(7):928-934. doi:10.1007/s00595- 010-4397-7 9. Zogg CK, Mungo B, Lidor AO, et al. Influ - ence of body mass index on outcomes after major resection for cancer. Surg (United States) . 2015;158(2):472-485. doi:10.1016/j. surg.2015.02.023 10. Lennon H, Sperrin M, Badrick E, Rene - han AG. The Obesity Paradox in Cancer: a Review. Curr Oncol Rep . 2016;18(9):1-8. doi:10.1007/s11912-016-0539-4 11. De La Garza G, Militsakh O, Panwar A, et al. Obesity and perioperative compli - cations in head and neck free tissue re- construction. In: Head and Neck . Vol 38. ; 2016:E1188-E1191. doi:10.1002/hed.24189 12. Khan MN, Russo J, Spivack J, et al. As - sociation of body mass index with infec- tious complications in free tissue trans- fer for head and neck reconstructive surgery. JAMA Otolaryngol - Head Neck Surg . 2017;143(6):574-579. doi:10.1001/ja - maoto.2016.4304 13. Wendrich AW, Swartz JE, Bril SI, et al. Low skeletal muscle mass is a predictive factor for chemotherapy dose-limiting toxicity in patients with locally advanced head and neck cancer. 2017. doi:10.1016/j.oraloncol - ogy.2017.05.012 14. Huiskamp LFJ, Chargi N, Devriese LA, de Jong PA, de Bree R. The predictive and prognostic value of low skeletal muscle mass for dose-limiting toxicity and survival in head and neck cancer patients receiving concomitant cetuximab and radiothera- py. Eur Arch Otorhinolaryngol . April 2020. doi:10.1007/s00405-020-05972-2 7